Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT00417040
Official study title

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

Study summary

This pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and Leukemia Group B (CALGB) studies. A study that evaluates a patient's ability to use a clinic waiting room computer to report their symptoms and their ability to carry out daily activities may help doctors understand a patient's use of a computer to report symptoms.

Ask AI to explain this study
Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiedinternet-based intervention and assessment of therapy complications

Plus 1 other study approaches.

Who it may be forProstate Cancer · Breast Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 27, 2017 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?95 U.S. locations

Locations may change over time.

Who runs it?Alliance for Clinical Trials in Oncology

Study sponsor

01
Study overview

What this study is about

Purpose
Other
Study type
Interventional
Phase
Not applicable
Sponsor
Alliance for Clinical Trials in Oncology
Interventions being studied
Other: internet-based intervention; Other: assessment of therapy complications; Other: Questionnaire Administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • DISEASE CHARACTERISTICS:
  • Enrolled on clinical trial CALGB-90401, CALGB-30607, CALGB-30704, CALGB-40601, CALGB-40603, CALGB-40502, CALGB-40503, CALGB-70604, or CALGB-80405 PATIENT CHARACTERISTICS:
  • Able to read and comprehend English language text
  • Able to see a computer screen (i.e., no visual impairments) or be accompanied at visits by someone who can read the screen for the patient PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • East Bay Radiation Oncology CenterCastro Valley, California
  • Valley Medical Oncology Consultants - Castro ValleyCastro Valley, California
  • Valley Medical OncologyFremont, California
  • Contra Costa Regional Medical CenterMartinez, California
  • El Camino Hospital Cancer CenterMountain View, California
  • Highland General HospitalOakland, California
  • Alta Bates Summit Medical Center - Summit CampusOakland, California
  • Bay Area Breast Surgeons, IncorporatedOakland, California
  • CCOP - Bay Area Tumor InstituteOakland, California
  • Larry G Strieff MD Medical CorporationOakland, California
  • Tom K Lee, IncorporatedOakland, California
  • UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 27, 2017. Always confirm current availability with the study team.

View original record ↗